| Shipment Reliability and Frequency | Volume of Goods |
|---|---|
| Avg. Shipments per Month: 0.92 | Average TEU per month: 1.38 |
| Active Months: 2 | Average TEU per Shipment: 1.50 |
| Shipment Frequency Std. Dev.: 2.15 |
| Company Name | Shipments |
|---|---|
| MYLAN PHARMACEUTICALS INC | 6 shipments |
| GREENSTONE LLC | 5 shipments |
| PPG INDUSTRIES INC | 1 shipments |
| HS Code | Shipments |
|---|---|
| 300439 Medicaments; containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | 11 shipments |
| 210420 Homogenised composite food preparations | 1 shipments |
| Arrival Date | Bill Of Lading | Consignee | Weight | HS Code | Description |
|---|---|---|---|---|---|
| 2025-05-24 | EXDO6600120160 | MYLAN PHARMACEUTICALS INC | 3680.0 kg | 300439 | PHARMA HS:300439 HTS: |
| 2025-05-24 | EXDO6600120158 | MYLAN PHARMACEUTICALS INC | 2700.0 kg | 300439 | PHARMA HS:300439 HTS: |
| 2025-05-24 | EXDO6600120157 | MYLAN PHARMACEUTICALS INC | 2380.0 kg | 300439 | PHARMA HS:300439 HTS: |
| 2025-05-24 | EXDO6600120153 | MYLAN PHARMACEUTICALS INC | 2590.0 kg | 300439 | PHARMA HS:300439 HTS: |
| 2025-05-24 | EXDO6600120152 | MYLAN PHARMACEUTICALS INC | 3680.0 kg | 300439 | PHARMA HS CODE:300439 HTS: |
| 2025-05-24 | EXDO6600120149 | MYLAN PHARMACEUTICALS INC | 2563.0 kg | 300439 | PHARMA HS:300439 HTS: |
| 2025-04-25 | EXDO6600119419 | GREENSTONE LLC | 3700.0 kg | 300439 | HORMONE OR STEROID MEDICAMENTS HTS: 300439 |
| 2025-04-25 | EXDO6600119439 | GREENSTONE LLC | 3700.0 kg | 300439 | HORMONE OR STEROID MEDICAMENTS HTS: 300439 |
| 2025-04-25 | EXDO6600119441 | GREENSTONE LLC | 2292.0 kg | 300439 | HORMONE OR STEROID MEDICAMENTS HTS: 300439 |
| 2025-04-15 | EXDO6600119201 | GREENSTONE LLC | 3279.0 kg | 300439 | MEDICAL INSTRUMENTS HTS: 300439 |
| 2025-04-05 | EXDO6600119047 | GREENSTONE LLC | 2211.0 kg | 300439 | HORMONE OR STEROID MEDICAMENTS HTS: 300439 |
| 2024-10-16 | DSVFRTM0288665 | PPG INDUSTRIES INC | 18696.0 kg | 210420 | RESINSUN 1866 CL 3 III |